Suven Life Sciences Ltd SUVEN-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 03/05/21 IST
81.90quote price arrow down-1.85 (-2.21%)
Volume
306,797
52 week range
19.35 - 108.00

...

Loading . . .

KEY STATS

  • Open83.20
  • Day High84.10
  • Day Low80.60
  • Prev Close83.75
  • 52 Week High108.00
  • 52 Week High Date12/18/20
  • 52 Week Low19.35
  • 52 Week Low Date04/03/20
  • Market Cap142.61M
  • Shares Out127.28M
  • 10 Day Average Volume834,584.73
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change62.02

RATIOS/PROFITABILITY

  • EPS (TTM)-5.98
  • P/E (TTM)-13.69
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date02/14/2019
  • Div Amount1.50
  • Split Date-
  • Split Factor-

Latest Suven Life Sciences Ltd News

There is no recent news for this security.

Latest SUVEN-IN News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Suven Life Sciences Limited is a bio-pharmaceutical company. The Company is engaged in the business of manufacture and sale of bulk drugs and intermediaries. The Company's segments include Manufacturing (CRAMS), which develops and produces bulk drugs and intermediates under contract manufacturing services; Services (DDDSS), which consists of collaborative research projects (CRP), clinical trials, and testing and analysis services, and Research and Development. Its products...
Venkateswarlu Jasti
Chairman
P. Subba Rao Jr.
Chief Financial Officer
Address
SDE Serene Chambers 6th Floor
Road No. 5 Avenue 7, Banjara Hills
Hyderabad
500034
India